Fundz

Taiho Oncology Appoints Peter Melnyk as President & Chief Operating Officer

PRIVATEJan 20, 2026

Position

Chief Operating Officer

Company

Taiho Oncology

Peter Melnyk
PrincetonBiotechnologyHealth Care

Description

Taiho Oncology has announced the appointment of Peter Melnyk as President & Chief Operating Officer. He brings over 30 years of experience in oncology commercialization and leadership.

Quick answer

Taiho Oncology Appoints Peter Melnyk as President & Chief Operating Officer (January 20, 2026). Taiho Oncology is based in Princeton, New Jersey, United States.

Who is the new Chief Operating Officer at Taiho Oncology?
Taiho Oncology named Peter Melnyk Chief Operating Officer, announced January 20, 2026.
What did Taiho Oncology announce on January 20, 2026?
Taiho Oncology has announced the appointment of Peter Melnyk as President & Chief Operating Officer. He brings over 30 years of experience in oncology commercialization and leadership.
What does Taiho Oncology do?
Taiho Oncology, Inc. develops and commercializes novel treatments for hematologic malignancies and solid tumors.
Where is Taiho Oncology based?
Taiho Oncology is based in Princeton, New Jersey, United States.
Which similar companies made leadership changes around the same time?
BVI Medical (January 20, 2026), Angelini Pharma (January 21, 2026), CellCentric (January 19, 2026) and Ocular Therapeutix (January 21, 2026) also announced leadership changes within 45 days of Taiho Oncology.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Taiho Oncology, and when

A new leader at Taiho Oncology brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Taiho Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Taiho Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Taiho Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Taiho Oncology

Location

Princeton, New Jersey, United States

About

Taiho Oncology, Inc. develops and commercializes novel treatments for hematologic malignancies and solid tumors. The company's mission is to improve the lives of patients with cancer, their families, and their caregivers. Taiho Oncology has a robust pipeline of small-molecule clinical candidates targeting various tumor types.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Taiho Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Taiho Oncology's next move

Learn about Strategic plan

Taiho Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.